Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHODH | Q02127 | 3/20 | 0.40 |
| ▸ | MALT1 | Q9UDY8 | 2/20 | 0.35 |
| ▸ | SLC6A9 | P48067 | 5/20 | 0.33 |
| ▸ | NTRK1 | P04629 | 5/20 | 0.33 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.33 |
| ▸ | DRD4 | P21917 | 1/20 | 0.32 |
| ▸ | KIF18A | Q8NI77 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15698529 | 0.93 | DHODH (0.37) | DHODHMALT1SLC6A9NTRK1 | |
| SCHEMBL2083746 | 0.89 | DHODH (0.42) | DHODHMALT1NTRK1 | |
| SCHEMBL2293991 | 0.88 | P2RX7 (0.35) | MALT1SLC6A9NTRK1P2RX7 | |
| SCHEMBL4168969 | 0.88 | DHODH (0.41) | DHODHMALT1NTRK1KIF18A | |
| SCHEMBL31621733 | 0.87 | DHODH (0.42) | DHODHMALT1NTRK1 | |
| SCHEMBL950846 | 0.87 | DHODH (0.44) | DHODHMALT1NTRK1P2RX7DRD4 | |
| SCHEMBL2138302 | 0.86 | P2RX7 (0.41) | DHODHMALT1P2RX7DRD4 | |
| SCHEMBL28425563 | 0.86 | DHODH (0.41) | DHODHMALT1NTRK1P2RX7DRD4 | |
| Chlorantraniliprole SCHEMBL29551 | 0.86 | DHODH (0.44) | DHODHMALT1NTRK1DRD4 | |
| Chlorantraniliprole SCHEMBL29363261 | 0.86 | DHODH (0.44) | DHODHMALT1NTRK1DRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100035935-A1 | ANTHRANILAMIDE COMPOUNDS, PROCESS FOR THEIR PRODUCTION AND PESTICIDES CONTAINING THEM | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2010-02-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100035935-A1 | ANTHRANILAMIDE COMPOUNDS, PROCESS FOR THEIR PRODUCTION AND PESTICIDES CONTAINING THEM | AADAC, ANTXR2, DDT | DHODH 141/4885MALT1 4311/4885SLC6A9 3710/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.